Aviva’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.7M Buy
230,060
+25
+0% +$5.2K 0.08% 235
2026
Q1
$48.6M Buy
230,035
+3,774
+2% +$813K 0.08% 231
2025
Q4
$46.5M Buy
226,261
+6,031
+3% +$1.13M 0.08% 235
2025
Q3
$34.6M Buy
220,230
+24,602
+13% +$3.8M 0.06% 279
2025
Q2
$32.9M Buy
195,628
+12,163
+7% +$1.81M 0.07% 270
2025
Q1
$25.3M Buy
183,465
+37,644
+26% +$4.8M 0.06% 301
2024
Q4
$17.2M Sell
145,821
-188,088
-56% -$22M 0.04% 348
2024
Q3
$36.9M Buy
333,909
+7,590
+2% +$794K 0.1% 255
2024
Q2
$32.1M Buy
326,319
+32,041
+11% +$3.26M 0.09% 262
2024
Q1
$32.9M Buy
294,278
+211,532
+256% +$22.8M 0.11% 222
2023
Q4
$8.34M Sell
82,746
-13,744
-14% -$1.36M 0.03% 467
2023
Q3
$8.38M Buy
96,490
+2,009
+2% +$182K 0.04% 436
2023
Q2
$8.94M Sell
94,481
-133,131
-58% -$11.2M 0.04% 443
2023
Q1
$17.2M Sell
227,612
-34,231
-13% -$2.58M 0.08% 374
2022
Q4
$20.1M Buy
261,843
+49,496
+23% +$3.76M 0.1% 296
2022
Q3
$14.2M Buy
212,347
+23,693
+13% +$1.5M 0.08% 344
2022
Q2
$9.86M Buy
188,654
+75,977
+67% +$4.32M 0.05% 444
2022
Q1
$6.39M Buy
112,677
+26,010
+30% +$1.39M 0.03% 542
2021
Q4
$4.46M Sell
86,667
-2,061
-2% -$101K 0.02% 616
2021
Q3
$4.39M Sell
88,728
-5,884
-6% -$319K 0.02% 608
2021
Q2
$5.4M Sell
94,612
-2,577
-3% -$151K 0.02% 577
2021
Q1
$5.9M Sell
97,189
-153
-0.2% -$8.45K 0.03% 486
2020
Q4
$5.21M Buy
97,342
+3,115
+3% +$162K 0.03% 492
2020
Q3
$4.42M Sell
94,227
-3,030
-3% -$155K 0.03% 479
2020
Q2
$5.08M Sell
97,257
-5,550
-5% -$286K 0.03% 419
2020
Q1
$4.93M Sell
102,807
-1,330
-1% -$69.1K 0.04% 404
2019
Q4
$5.27M Sell
104,137
-978
-0.9% -$50.5K 0.03% 450
2019
Q3
$4.96M Sell
105,115
-5,153
-5% -$235K 0.03% 428
2019
Q2
$5.19M Sell
110,268
-2,377
-2% -$110K 0.04% 438
2019
Q1
$5.42M Sell
112,645
-3,173
-3% -$159K 0.04% 424
2018
Q4
$5.17M Sell
115,818
-34,945
-23% -$1.82M 0.04% 414
2018
Q3
$8.14M Sell
150,763
-33,420
-18% -$1.71M 0.04% 379
2018
Q2
$8.99M Buy
184,183
+22,797
+14% +$1.29M 0.05% 336
2018
Q1
$10.1M Sell
161,386
-14,692
-8% -$1.01M 0.06% 305
2017
Q4
$10.8M Sell
176,078
-25,442
-13% -$1.57M 0.06% 317
2017
Q3
$13.5M Buy
201,520
+1,610
+0.8% +$114K 0.07% 283
2017
Q2
$15.6M Buy
199,910
+1,550
+0.8% +$117K 0.09% 260
2017
Q1
$16.2M Sell
198,360
-10,231
-5% -$805K 0.09% 240
2016
Q4
$15M Buy
208,591
+11,227
+6% +$812K 0.09% 246
2016
Q3
$15.3M Sell
197,364
-15,017
-7% -$1.21M 0.1% 245
2016
Q2
$16.6M Buy
212,381
+29,150
+16% +$2.32M 0.11% 208
2016
Q1
$15M Buy
183,231
+1,322
+0.7% +$107K 0.11% 197
2015
Q4
$16.2M Sell
181,909
-1,104
-0.6% -$93.7K 0.12% 179
2015
Q3
$14.1M Sell
183,013
-4,353
-2% -$364K 0.12% 204
2015
Q2
$15.7M Buy
187,366
+9,550
+5% +$843K 0.11% 211
2015
Q1
$16.1M Buy
177,816
+39,220
+28% +$3.38M 0.11% 209
2014
Q4
$11.2M Sell
138,596
-830
-0.6% -$65.5K 0.09% 261
2014
Q3
$10.4M Sell
139,426
-1,000
-0.7% -$72.8K 0.08% 270
2014
Q2
$9.63M Sell
140,426
-1,010
-0.7% -$68.8K 0.07% 302
2014
Q1
$9.9M Sell
141,436
-46,185
-25% -$3.21M 0.08% 277
2013
Q4
$12.5M Sell
187,621
-47,799
-20% -$2.92M 0.1% 220
2013
Q3
$12.3M Buy
235,420
+30,612
+15% +$1.56M 0.11% 225
2013
Q2
$9.67M Buy
+204,808
New +$9.35M 0.1% 236

Other funds holding CAH

Aviva's CAH Position: Q2 2026 in Review

Aviva increased its Cardinal Health (CAH) stake by 0.01% in Q2 2026, buying an estimated $5.2K and bringing the position to 230,060 shares worth $54.7M. The position accounts for 0.08% of the portfolio, ranked #235.

Aviva first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Aviva held 230,060 shares of Cardinal Health worth $54.7M as of Q2 2026.
  • Aviva bought 25 Cardinal Health shares in Q2 2026, an estimated $5.2K.
  • Cardinal Health made up 0.08% of Aviva's portfolio in Q2 2026, its #235 holding.
  • Aviva first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.